Linscomb & Williams, Inc. Danaher Corp Transaction History

Linscomb & Williams, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $361,647 - $422,870	1,498 New	1,498 $397,000
Q2 2022 Aug 15, 2022	SELL	$237.11 - $299.66 $404,746 - $511,519	-1,707 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$257.27 - $315.76 $129,921 - $159,458	505 Added 42.01%	1,707 $501,000
Q4 2021 Feb 10, 2022	SELL	$292.08 - $329.01 $94,926 - $106,928	-325 Reduced 21.28%	1,202 $396,000
Q3 2021 Nov 03, 2021	BUY	$272.21 - $332.43 $117,322 - $143,277	431 Added 39.32%	1,527 $465,000
Q2 2021 Aug 10, 2021	BUY	$225.08 - $271.69 $246,687 - $297,772	1,096 New	1,096 $294,000

2,483

543M

7.08M

4.54M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $162B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Linscomb & Williams, Inc., based on Form 13F filings with the SEC.

Stay updated on Linscomb & Williams, Inc. with notifications on news.